当前位置:首页 - 行情中心 - 昊帆生物(301393) - 财务分析 - 现金流量表

昊帆生物

(301393)

  

流通市值:26.27亿  总市值:67.38亿
流通股本:4210.48万   总股本:1.08亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金281,022,495.96565,030,482.86351,177,040.14219,281,466.18
  收到的税费返还5,958,027.9217,945,454.6913,832,636.929,525,220.98
  收到其他与经营活动有关的现金2,779,965.0925,946,920.0128,565,978.8412,320,633.32
  经营活动现金流入小计289,760,488.97608,922,857.56393,575,655.9241,127,320.48
  购买商品、接受劳务支付的现金94,943,855.46373,158,287.4217,791,133.04117,417,889.1
  支付给职工以及为职工支付的现金31,883,582.4881,578,891.5862,338,254.8140,461,338.72
  支付的各项税费15,744,040.6352,923,235.4535,699,508.6224,022,829.79
  支付其他与经营活动有关的现金72,355,116.5223,592,850.5130,023,630.8414,147,395.58
  经营活动现金流出小计214,926,595.09531,253,264.94345,852,527.31196,049,453.19
  经营活动产生的现金流量净额74,833,893.8877,669,592.6247,723,128.5945,077,867.29
二、投资活动产生的现金流量:
  收回投资收到的现金1,260,000,0005,698,287,444.314,018,603,927.452,301,963,026.62
  取得投资收益收到的现金4,753,887.6325,386,897.530-
  处置固定资产、无形资产和其他长期资产收回的现金净额-159,403.161,917,558.641,398,499.02
  处置子公司及其他营业单位收到的现金净额--0-
  收到的其他与投资活动有关的现金-16,960,701.4911,000,00011,500,000
  投资活动现金流入小计1,264,753,887.635,740,794,446.494,031,521,486.092,314,861,525.64
  购建固定资产、无形资产和其他长期资产支付的现金127,275,597.58210,626,615.3592,288,821.8754,617,680.88
  投资支付的现金1,356,692,4005,377,609,551.63,529,046,308.41,664,046,308.4
  质押贷款净增加额--0-
  取得子公司及其他营业单位支付的现金-55,603,114.9855,603,114.98-
  支付其他与投资活动有关的现金1,000,000200,000200,000200,000
  投资活动现金流出小计1,484,967,997.585,644,039,281.933,677,138,245.251,718,863,989.28
  投资活动产生的现金流量净额-220,214,109.9596,755,164.56354,383,240.84595,997,536.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金-4,601,1004,601,100-
  取得借款收到的现金36,708,067.2114,467,052.475,000,000-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计36,708,067.2119,068,152.479,601,100-
  偿还债务支付的现金-195,990,000195,990,000-
  分配股利、利润或偿付利息支付的现金90,250.0243,442,411.9528,881,609.1328,347,540.78
  支付其他与筹资活动有关的现金236,228.41,946,879.941,458,548.53734,874.9
  筹资活动现金流出小计326,478.42241,379,291.89226,330,157.6629,082,415.68
  筹资活动产生的现金流量净额36,381,588.78-122,311,139.49-146,729,057.66-29,082,415.68
四、汇率变动对现金及现金等价物的影响-1,511,526.52-6,710,583.67-3,639,489.76-1,206,677.33
五、现金及现金等价物净增加额-110,510,153.8145,403,034.02251,737,822.01610,786,310.64
  加:期初现金及现金等价物余额406,483,479.95361,081,038.91361,081,038.91361,081,038.91
  期末现金及现金等价物余额295,973,326.14406,484,072.93612,818,860.92971,867,349.55
补充资料:
  净利润-110,844,322.74-75,884,801.99
  资产减值准备-4,245,056.81-997,998.58
  固定资产和投资性房地产折旧-34,292,219.75-12,718,771.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,292,219.75-12,718,771.51
  无形资产摊销-1,808,603.43-288,335.26
  长期待摊费用摊销-371,219.48-70,412.98
  处置固定资产、无形资产和其他长期资产的损失-907,512.14-93,989.15
  固定资产报废损失-14,103,290.04-30,860.38
  公允价值变动损失--7,240,295.4--5,444,086.14
  财务费用-8,025,955.45-1,410,756.05
  投资损失--17,251,963.74--9,950,840.4
  递延所得税--3,186,448.95--673,997.09
  其中:递延所得税资产减少--2,028,664.05--396,345.74
    递延所得税负债增加--1,157,784.9--277,651.35
  存货的减少--13,747,401.77--21,251,383.03
  经营性应收项目的减少-146,153,007.95--39,907,425.79
  经营性应付项目的增加--211,373,107.48-27,017,450.77
  其他-7,926,434.65-2,897,780.19
  现金的期末余额-406,484,072.93-971,867,349.55
  减:现金的期初余额-361,081,038.91-361,081,038.91
  现金及现金等价物的净增加额-45,403,034.02-610,786,310.64
公告日期2026-04-242026-04-172025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑